menu search

KTRA / Kintara Therapeutics to Present at the Emerging Growth Conference

Kintara Therapeutics to Present at the Emerging Growth Conference
SAN DIEGO , Aug. 9, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that its President and CEO, Robert E. Hoffman will present in the Emerging Growth Conference on Wednesday, August 9, 2023 at 12:00 pm ET. Read More
Posted: Aug 9 2023, 08:16
Author Name: PRNewsWire
Views: 122441

KTRA News  

Kintara Therapeutics to Present at the Emerging Growth Conference

By PRNewsWire
August 9, 2023

Kintara Therapeutics to Present at the Emerging Growth Conference

SAN DIEGO , Aug. 9, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused more_horizontal

Kintara (KTRA) Rises 41% on $2M Grant for Breast Cancer Therapy

By Zacks Investment Research
June 30, 2023

Kintara (KTRA) Rises 41% on $2M Grant for Breast Cancer Therapy

Kintara (KTRA) receives a $2 million grant from the National Institutes of Health to develop its breast cancer treatment candidate, REM-001. The stock more_horizontal

Kintara Therapeutics Scheduled to Present at Two Conferences the Week of March 13, 2023

By PRNewsWire
March 10, 2023

Kintara Therapeutics Scheduled to Present at Two Conferences the Week of March 13, 2023

-35th Annual ROTH Conference, March 12-14, 2023 – -4th Annual Glioblastoma Drug Development Summit, March 14-16, 2023- SAN DIEGO , March 10, 2023 /P more_horizontal

Is Kintara Therapeutics A Hidden Gem?

By MarketBeat
December 30, 2022

Is Kintara Therapeutics A Hidden Gem?

Kintara Therapeutics' earnings are in the red but impressive FDA approvals could satisfy an extreme upside potential to bring them solvent by next yea more_horizontal

Why Kintara Therapeutics Stock Is Seeing Blue Skies Thursday - Kintara Therapeutics (NASDAQ:KTRA)

By Benzinga
December 15, 2022

Why Kintara Therapeutics Stock Is Seeing Blue Skies Thursday - Kintara Therapeutics (NASDAQ:KTRA)

Kintara Therapeutics Inc KTRA shares are trading higher by 24.09% to $9.94 Thursday morning after the company received FDA Orphan Drug Designation (O more_horizontal

Kintara Therapeutics to Present at the Alliance Global Partners Summer Healthcare Conference

By PRNewsWire
June 21, 2022

Kintara Therapeutics to Present at the Alliance Global Partners Summer Healthcare Conference

SAN DIEGO , June 21, 2022 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused more_horizontal

Why Kintara Therapeutics Shares Are Skyrocketing Today

By Benzinga
June 15, 2022

Why Kintara Therapeutics Shares Are Skyrocketing Today

Kintara Therapeutics Inc (NASDAQ: KTRA) shares are trading higher by 28.6% to $0.24 after the FDA granted Fast Track Designation to the company's VAL- more_horizontal

Best Penny Stocks to Buy Today? 3 Climbing In Morning Trading

By PennyStocks
April 27, 2022

Best Penny Stocks to Buy Today? 3 Climbing In Morning Trading

Here's what you need to know about trading penny stocks on April 27th The post Best Penny Stocks to Buy Today? 3 Climbing In Morning Trading  appeare more_horizontal


Search within

Pages Search Results: